These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2614087)

  • 21. Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast disease.
    Allende MT; Vizoso F; Mosquera E; Fernández Fernández M; Fernández Llana B; Ruibal A
    Int J Biol Markers; 1991; 6(3):199-200. PubMed ID: 1791316
    [No Abstract]   [Full Text] [Related]  

  • 22. The biochemistry of cyst fluids.
    Miller WR
    Br J Clin Pract Suppl; 1989 Nov; 68():94-9; discussion 111-5. PubMed ID: 2488573
    [No Abstract]   [Full Text] [Related]  

  • 23. CA-125 is not a useful marker in metastatic breast cancer.
    Seckl MJ; Rustin GJ; Coombes RC
    Br J Cancer; 1992 Nov; 66(5):875-6. PubMed ID: 1419631
    [No Abstract]   [Full Text] [Related]  

  • 24. [The intracystic concentration of MCA in the fluid from large breast cysts].
    Mezi S; Reale MG; Aloise G; Marigliani A; Marchei CG; Sallusti E; Mentuccia D; Del Nero A; Izzo P; Modesti M
    G Chir; 1999 May; 20(5):246-51. PubMed ID: 10380368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers in breast cancer: does CEA add to the detection by CA 15.3?
    Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
    Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of clinical studies of CA 27.29 in breast cancer management.
    Beveridge RA
    Int J Biol Markers; 1999; 14(1):36-9. PubMed ID: 10367248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cation levels in human breast cyst fluid.
    Bradlow HL; Skidmore FD; Schwartz MK; Fleisher M
    Clin Oncol; 1981 Dec; 7(4):388-90. PubMed ID: 7318283
    [No Abstract]   [Full Text] [Related]  

  • 29. Breast cancer risk with cyst type in cystic disease of the breast. Larger study found no association between cyst type and breast cancer.
    Dixon JM; McDonald C; Elton RA; Miller WR
    BMJ; 1997 Aug; 315(7107):545-6. PubMed ID: 9329317
    [No Abstract]   [Full Text] [Related]  

  • 30. [The value of tumor markers CA 15-3 and CEA in breast cancer].
    Buck I; Lindner C; Böge K; Kitschke HJ
    Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha 1-antichymotrypsin complexes in human breast cyst fluids.
    Mannello F; Malatesta M; Bocchiotti G; Gazzanelli G
    Cancer Lett; 1994 Jan; 76(2-3):155-9. PubMed ID: 8149344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemistry of cyst fluid in fibrocystic disease of the breast. Approach to classification and understanding of the mechanism of formation.
    Molina R; Filella X; Herranz M; Prats M; Velasco A; Zanon G; Martinez-Osaba MJ; Ballesta AM
    Ann N Y Acad Sci; 1990; 586():29-42. PubMed ID: 2357010
    [No Abstract]   [Full Text] [Related]  

  • 33. [Initial experiences with CA-15-3 determination in the serum of patients with breast cancer].
    Bartel U; Johannsen B; Reiss H; Elling D
    Zentralbl Gynakol; 1989; 111(21):1417-24. PubMed ID: 2557715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LAI test in specific immune-reactivity studies of fibrocytic breast disease.
    Cavallini G; Berti G
    Tumori; 1982 Aug; 68(4):291-4. PubMed ID: 7147353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 37. CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.
    Bombardieri E; Pizzichetta M; Veronesi P; Seregni E; Bogni A; Maffioli L; Jotti GS; Bassetto MA; Zurrida S; Costa A
    Eur J Cancer; 1992; 29A(1):144-6. PubMed ID: 1445733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-associated sialic acid levels in human breast cyst fluids.
    Mannello F; Bocchiotti G; Troccoli R; Gazzanelli G
    Breast Cancer Res Treat; 1992; 24(2):167-70. PubMed ID: 8443404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of a human tumor marker (Ca 72-4) in animal seminal plasma.
    Uhlenbruck G; Dietz E; Schmid DO; Haeger O
    Naturwissenschaften; 1988 Jul; 75(7):359-60. PubMed ID: 3211208
    [No Abstract]   [Full Text] [Related]  

  • 40. Nonlinearity of measurements of a tumor marker for breast cancer.
    Cooper EH; Forbes MA; Laurence V; Beya MF; de Chastonay J
    Clin Chem; 1990 Feb; 36(2):408-9. PubMed ID: 2406045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.